HYDERABAD: On a day that India threw open vaccinations to all residents over 18 years of age, the primary lot of 1.5 lakh Russian Covid-19 vaccines Sputnik V arrived in Hyderabad from Russia.
The firm stated that the rollout of the consignment might be topic to the required clearances, which might be processed over the following few days.
“This initial quantity will be used across different channels as a pilot to line up our supply chain for the larger vaccination program rollout. Subsequent consignments will arrive in the next few weeks,”Dr Reddy’s Laboratories CEO (API& Services) Deepak Sapra stated.
The imported vaccine is prone to be priced at round $10 per dose according to the uniform international pricing, prime firm officers had stated earlier.
Dr Reddy’s has tied up with Russian sovereign fund Russian Direct Investment Fund (RDIF) for distributing over 125 million individuals equal doses of Sputnik V in India. Sputnik V includes two human adenoviral vectors – Advert26 and Ad5 — that might be injected 21 days aside.
RDIF has tied up with Gland Pharma (252 m), Hetero Biopharma (100 million), Virchow Biotech (200 m), Panacea Biotech (100 m) and Stelis Biopharma (200 m), to fabricate 852 million doses or 426 million individuals equal doses of Sputnik V, whereas Dr Reddy’s has a tie-up with Shilpa Medicare for an undisclosed variety of doses.